Cargando…
An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer
OBJECTIVE: The statin family of cholesterol-lowering drugs has been shown to induce tumor-specific apoptosis by inhibiting the rate-limiting enzyme of the mevalonate (MVA) pathway, HMG-CoA reductase (HMGCR). Accumulating evidence suggests that statin use may delay prostate cancer (PCa) progression i...
Autores principales: | Longo, Joseph, Mullen, Peter J., Yu, Rosemary, van Leeuwen, Jenna E., Masoomian, Mehdi, Woon, Dixon T.S., Wang, Yuzhuo, Chen, Eric X., Hamilton, Robert J., Sweet, Joan M., van der Kwast, Theodorus H., Fleshner, Neil E., Penn, Linda Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600047/ https://www.ncbi.nlm.nih.gov/pubmed/31023626 http://dx.doi.org/10.1016/j.molmet.2019.04.003 |
Ejemplares similares
-
A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer
por: Longo, Joseph, et al.
Publicado: (2020) -
Novel Multiplex MethyLight Protocol for Detection of DNA Methylation in Patient Tissues and Bodily Fluids
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2014) -
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression
por: Kamdar, Shivani, et al.
Publicado: (2019) -
Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2017) -
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins
por: van Leeuwen, Jenna E., et al.
Publicado: (2022)